Moneycontrol

You are Here : Sun Pharma falls 3% as Shanghvi sees single digit decline in FY18 revenue

Wednesday, 12:56

Sun Pharma is eagerly awaiting the re-inspection of Halol facility by the US Food and Drug Administration, after completion of remedial activities.
OCT 20, 2017
01:55 AM

cnbc tv18 shows

Search
All Shows
Go

mytv on mobile

Track your portfolio on the go with

moneycontrol app

Sections
Follow us on
Available On